{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:26:02Z","timestamp":1794288362981,"version":"4.9.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>The optimal cutoff for soluble interleukin-2 receptor in this study was 2515 U\/mL (sensitivity, 100%; specificity, 72.5%). sIL-2r \u22642400 U\/mL is helpful for ruling out HLH (sensitivity, 100%) and &gt;10\u2009000 U\/mL is helpful for ruling it in (specificity, 93%).<\/jats:p>","DOI":"10.1182\/bloodadvances.2017012310","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T20:35:13Z","timestamp":1512592513000},"page":"2529-2534","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":188,"title":["Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH"],"prefix":"10.1182","volume":"1","author":[{"given":"Anna","family":"Hayden","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Pudek","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Schneider","sequence":"additional","affiliation":[{"name":"Division of Experimental Anesthesiology, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Division of Immunology and"},{"name":"Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Mattman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2951","authenticated-orcid":false,"given":"Luke Y. C.","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"issue":"15","key":"2019111617034501500_B1","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"2019111617034501500_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2019111617034501500_B3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"21-22","key":"2019111617034501500_B4","first-page":"299","article-title":"Haemophagocytic syndromes in adults: current concepts and challenges ahead","volume":"135","author":"Emmenegger","year":"2005","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"2019111617034501500_B5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/imj.12768","article-title":"Conditions associated with extreme hyperferritinaemia (>3000 \u03bcg\/L) in adults","volume":"45","author":"Wormsbecker","year":"2015","journal-title":"Intern Med J"},{"issue":"10","key":"2019111617034501500_B6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2019111617034501500_B7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev"},{"issue":"3","key":"2019111617034501500_B8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjh.12138","article-title":"Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis","volume":"160","author":"Lehmberg","year":"2013","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111617034501500_B9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"issue":"8","key":"2019111617034501500_B10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00277-017-2993-y","article-title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","volume":"96","author":"Lin","year":"2017","journal-title":"Ann Hematol"},{"issue":"1","key":"2019111617034501500_B11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","article-title":"Modern management of children with haemophagocytic lymphohistiocytosis","volume":"124","author":"Janka","year":"2004","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111617034501500_B12","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"issue":"5","key":"2019111617034501500_B13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","article-title":"A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Tsuji","year":"2014","journal-title":"Ann Hematol"},{"issue":"9","key":"2019111617034501500_B14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2019111617034501500_B15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"22","key":"2019111617034501500_B16","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2016-12-753830","article-title":"Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH","volume":"129","author":"Rubin","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2019111617034501500_B17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2019111617034501500_B18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/26\/2529\/879928\/advances012310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/26\/2529\/879928\/advances012310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T17:03:59Z","timestamp":1573923839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/26\/2529\/16250\/Soluble-interleukin2-receptor-is-a-sensitive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":18,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2017,12,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017012310","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,6]]}}}